The Office of the Auditor General’s report for 2023 said that $871m worth of drugs which have been paid for were still to be delivered as of September this year.
Western Scientific Company at $291m and New GPC Incorporated at $224m were the major defaulters.
The report tabled in the National Assembly on Thursday said that “Outstanding deliveries amounted to $5.466 billion as at December 2023. As at August 2024, deliveries totalling $2.106 billion were delivered leaving a balance of $870.955M of Drugs and Medical Supplies paid for and yet to be delivered. Similarly, as it relates to 2022, $147.605M is yet to be delivered”.
